Challenges and Opportunities With Oncology Drug Development in China (original) (raw)
Cancer drug development in China: recent advances and future challenges
yumei yang
Drug discovery today, 2014
View PDFchevron_right
The rise of immuno-oncology in China: a challenge to western dominance?
Richard Sullivan
Lancet Oncology, 2023
View PDFchevron_right
The global significance of China's cancer burden and control effort
Lihua Liu
Annals of translational medicine, 2014
View PDFchevron_right
Proceedings of the Strategy Meeting for the Development of an International Consortium for Chinese Medicine and Cancer
Jeffrey White
Journal of Global Oncology, 2016
View PDFchevron_right
US National Cancer Institute–China Collaborative Studies on Chinese Medicine and Cancer
Jeffrey White
JNCI Monographs, 2017
View PDFchevron_right
Cancer care in China: A general review
Weining Zhen
Biomedical Imaging and Intervention Journal, 2008
View PDFchevron_right
Challenges to effective cancer control in China, India, and Russia
Richard Sullivan
View PDFchevron_right
China's unique position in discovery and preclinical research
Roman Boutellier
Drug discovery today, 2007
View PDFchevron_right
The Pharma Industry and China IHEST Update October 2015
A. Hénaut
View PDFchevron_right
Chinese health biotech and the billion-patient market
Stephen Sammut
Nature Biotechnology, 2008
View PDFchevron_right
Regional Disparity in First-in-Class Anticancer Drug Development in the US, EU, and Japan
Randell Doty
Biological and Pharmaceutical Bulletin
View PDFchevron_right
Toward Optimum Benefit-Risk and Reduced Access Lag For Cancer Drugs in Asia: A Global Development Framework Guided by Clinical Pharmacology Principles
Ajit Suri
Clinical and translational science, 2016
View PDFchevron_right
Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s)
International Journal of Health Policy and Management IJHPM, Chao-chen Chung
2015
View PDFchevron_right
Traditional Chinese Medicine in Cancer Care: An overview of randomized controlled trials published in Chinese
Lisa Wieland
Advances in Integrative Medicine, 2019
View PDFchevron_right
Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting
Richard Sullivan
JCO Global Oncol, 2024
View PDFchevron_right
The increasing impact of Chinese innovative drug research on the global stage with a focus on drug discovery
Peng Zhan
Expert Opinion on Drug Discovery, 2020
View PDFchevron_right
Meeting Report The 7th Asia Cancer Forum: From the Perspective of Human Security, How Can We Collaborate as Asians in Order to Place Cancer on the Global Health Agenda? How Can We Fill in the Gaps that Exist Among Us?
Norie Kawahara
2011
View PDFchevron_right
Expenditure of hospital care on cancer in China, from 2011 to 2015
Lan Lan
Chinese Journal of Cancer Research, 2017
View PDFchevron_right
The role of funding and policies on innovation in cancer drug development
Richard Sullivan
View PDFchevron_right
Discussing Solutions for Cancer Treatment at the Cancer Center of Bai Chay Hospital, Quang Ninh - And Experiences from Other Countries
AJAST Journal
Middle East Journal of Applied Science & Technology, 2022
View PDFchevron_right
Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?
Hideki Maeda
View PDFchevron_right
Cancer survival in Shanghai, China, 1992-1995
Yu-Tang Gao
IARC scientific publications, 2011
View PDFchevron_right
The 7th Asia Cancer Forum: From the Perspective of Human Security, How Can We Collaborate as Asians in Order to Place Cancer on the Global Health Agenda? How Can We Fill in the Gaps that Exist Among Us?
Norie Kawahara
Japanese Journal of Clinical Oncology, 2011
View PDFchevron_right
The notorious “drug lag” for oncology drugs in Japan
Noriyuki Katsumata
Investigational New Drugs, 2011
View PDFchevron_right
Traditional Chinese Medicine in Cancer Care: A Review of Controlled Clinical Studies Published in Chinese
Guoyan Yang
PLOS ONE, 2013
View PDFchevron_right
Chinese Journal of Clinical Oncolgy
Daisy Liu
2004
View PDFchevron_right
2nd International China BioPharmaceutical Symposium
Mason Soule
Expert Review of Clinical Pharmacology, 2009
View PDFchevron_right
Overview of Oncology and Hematology Drug Approvals at US Food and Drug Administration Between 2008 and 2016
Jonathon Vallejo
JNCI: Journal of the National Cancer Institute, 2018
View PDFchevron_right
Patterns and Trends with Cancer Incidence and Mortality Rates Reported by the China National Cancer Registry
jing chai
Asian Pacific Journal of Cancer Prevention, 2014
View PDFchevron_right
Oncology drug development: United States Food and Drug Administration perspective
Steven Hirschfeld
Critical reviews in oncology/hematology, 2002
View PDFchevron_right
Traditional Chinese Medicine in Cancer Care: A Review of Case Series Published in the Chinese Literature
xun li
Evidence-Based Complementary and Alternative Medicine, 2012
View PDFchevron_right